0001104659-23-004642.txt : 20230118 0001104659-23-004642.hdr.sgml : 20230118 20230118170155 ACCESSION NUMBER: 0001104659-23-004642 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230113 FILED AS OF DATE: 20230118 DATE AS OF CHANGE: 20230118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Raphael Erez CENTRAL INDEX KEY: 0001668046 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37704 FILM NUMBER: 23535042 MAIL ADDRESS: STREET 1: 9 HALAMISH STREET STREET 2: CAESAREA INDUSTRIAL PARK CITY: CAESAREA STATE: L3 ZIP: 38900 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DarioHealth Corp. CENTRAL INDEX KEY: 0001533998 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 452973162 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 18 W 18TH ST., 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10011 BUSINESS PHONE: 646.665.4667 MAIL ADDRESS: STREET 1: 18 W 18TH ST., 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10011 FORMER COMPANY: FORMER CONFORMED NAME: LabStyle Innovations Corp. DATE OF NAME CHANGE: 20111101 4 1 tm233645-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2023-01-13 0 0001533998 DarioHealth Corp. DRIO 0001668046 Raphael Erez 18 W. 18TH ST, 5TH FLOOR NEW YORK NY 10011 1 1 0 0 Chief Executive Officer Common Stock 2023-01-13 4 S 0 1200 6.2075 D 1112059 D Common Stock 37876 I By Dicilyon Consulting and Investment Ltd. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 2, 2022. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.20 to $6.23, inclusive. The Reporting Person undertakes to provide to DarioHealth Corp. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2). The amount shown represents the beneficial ownership of the issuer's securities held by Dicilyon Consulting and Investment Ltd. which may be deemed to be attributable to Mr. Raphael because Mr. Raphael possesses voting and dispositive power over the securities held by Dicilyon Consulting and Investment Ltd. by virtue of a proxy. Mr. Raphael disclaims beneficial ownership of the securities set forth herein. /s/ Erez Raphael 2023-01-18